Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP1585 vs Sevelamer in CKD Hyperphosphatemia
NCT01057407Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2010
- Primary completion
- Sep 2010
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bixalomer in hyperphosphatemia, sponsored by Astellas Pharma. Started Jan 2010; status: completed.
02
Drugs
bixalomer
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT01057407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01057407.